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BATF regulates the development and function
of IL-17 producing iNKT cells
Kimberly L Jordan-Williams1, Stacie Poston1 and Elizabeth J Taparowsky2*
Abstract
Background: BATF plays important roles in the function of the immune system. Batf null mice are deficient in both
CD4+ Th17 cells and T follicular helper cells and possess an intrinsic B cell defect that leads to the complete
absence of class switched Ig. In this study, Tg mice overexpressing BATF in T cells were used together with Batf null
mice to investigate how altering levels of BATF expression in T cells impacts the development and function of a
recently characterized population of iNKT cells expressing IL-17 (iNKT-17).
Results: BATF has a direct impact on IL-17 expression by iNKT cells. However, in contrast to the Th17 lineage where
BATF activates IL-17 expression and leads to the expansion of the lineage, BATF overexpression restricts overall iNKT
cell numbers while skewing the compartment in vivo and in vitro toward an iNKT-17 phenotype.
Conclusions: This work is the first to demonstrate that BATF joins RORγt as the molecular signature for all IL-17
producing cells in vivo and identifies BATF as a component of the nuclear protein network that could be targeted
to regulate IL-17-mediated disease. Interestingly, these studies also reveal that while the Il17a gene is a common
target for BATF regulation in Th17 and iNKT-17 cells, this regulation is accompanied by opposite effects on the
growth and expansion of these two cell lineages.
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Background
BATF is a basic leucine zipper transcription factor that
dimerizes with the JUN proteins to direct patterns of ac-
tivator protein-1 (AP-1)-mediated gene expression in the
immune system [1]. The impact of disrupting BATF
function in vivo has been examined by several groups
[2-5]. Mice in which BATF is overexpressed using a T
cell-specific promoter display a reduced number of
iNKT cells [6], an increased number of CD4+ T cells ex-
pressing IL-17 (Th17) [5] and an altered cytokine envir-
onment that promotes the gross overproduction of class
switched Ig by B cells [7]. Batf null mice are viable, yet
display a severe deficiency in Th17 and T follicular
helper cells [2,3,5]. The T cell deficiencies are combined
with an intrinsic B cell defect blocking the production of
class switched Ig to impair the immune response of
these animals to antigen challenge [2,3]. The dramatic
consequences of altering BATF expression in vivo
provides evidence that BATF functions to coordinate im-
mune system activities critical in autoimmunity, inflam-
mation and the host response to pathogens.
The ability of BATF to promote the differentiation of
naïve CD4+ T cells to the Th17 lineage has been shown to
rely on the formation of IRF4/BATF protein complexes
that bind and transactivate a number of genes, including
Il17a/f [8]. Interestingly, we have observed a negative in-
fluence of BATF on the development of iNKT cells [6,9]
and therefore sought to examine how these two opposing
activities of BATF may influence the development of a re-
cently identified subset of iNKT cells that expresses IL-17
[10-13]. Murine iNKT-17 cells are a CD4- NK1.1- popula-
tion that is enriched in peripheral LN (PLN) and respond
following stimulation by rapidly secreting IL-17. iNKT-17
cells express RORγt and additional markers that define
them as a lineage distinct from classic iNKT cells. A role
for iNKT-17 cells has been demonstrated in experimental
models of airway disease, asthma and collagen-induced
arthritis [12,14,15]. iNKT-17 cells are over-represented in
NOD mice where their influence in the pancreas exacer-
bates the development of diabetes [16]. In the present
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study, using mouse models of BATF overexpression (CD2-
HA-BATF) and deficiency (BatfΔZ/ΔZ), we demonstrate the
importance of BATF to the development of iNKT-17 cells.
Despite the overall reduction in the number of iNKT cells
in CD2-HA-BATF mice, the majority express IL-17. Like-
wise, while peripheral iNKT cell numbers are increased in
BatfΔZ/ΔZ mice, the cells are deficient in IL-17 production.
These data are consistent with results in Th17 cells [5,17]
and suggest that BATF-containing protein complexes
transactivate the Il17a/f gene in NKT cells as well. The
novel finding is that the function of BATF as an IL-17 in-
ducer is separate from its effect on cell growth since Th17
cell numbers are expanded in the presence of BATF, while
iNKT cell numbers are reduced. To identify an in vitro
system that would facilitate the study of BATF-mediated
gene regulatory events relevant to the iNKT cell lineage,
we describe features of the DN32.D3 hybridoma [9] that
indicate similarity to the iNKT-17 lineage, including the
BATF-dependent expression of Il17a mRNA. We con-
clude that BATF joins RORγt as the molecular signature
for all IL-17 producing cells in vivo and represents an es-
sential component of a nuclear protein network that could
be targeted to regulate IL-17-mediated disease.
Results and discussion
BATF controls CD4+ Th17 cell differentiation
To test if CD2-HA-BATF Tg mice display the increase in
IL-17 expression reported for a separate model of BATF
overexpression in vivo [5], splenocytes were stimulated
with anti-CD3 and anti-CD28 antibodies and RNA iso-
lated after 48 h. For comparison, cells from non-Tg (WT)
and BatfΔZ/ΔZ mice were used. Gene expression analysis
by quantitative (q)RT-PCR revealed the expected high
level of Il17a mRNA in Tg cells and undetectable levels of
Il17a mRNA in BatfΔZ/ΔZ cells (Figure 1A). To implicate
altered Th17 development as the major contributor to this
change in Il17a expression, naïve CD4+ splenocytes from
Tg, WTand BatfΔZ/ΔZ mice were subjected to in vitro pro-
tocols skewing differentiation toward the Th17 lineage or
toward Th1 cells as a control. Differentiation was assessed
by measuring the expression of genes specific for these
CD4+ T cell subsets. As shown in Figure 1B, levels of Th1
associated transcripts (Tbet and Ifnγ) were statistically
similar across all samples, while levels of Th17 associated
transcripts (Rorγt, Il17a, Il23R and Il21) were elevated in
Tg samples and essentially undetectable in BatfΔZ/ΔZ sam-
ples (Figure 1C). These findings in CD2-HA-BATF mice
confirm a positive role for BATF in the differentiation of
Th17 cells.
Levels of BATF correlate with altered iNKT cell numbers
in vivo
Mice overexpressing BATF in thymic T cells (p56lck HA-
BATF) display a reduced number of iNKT cells [6].
Interestingly, quantification of thymic iNKT cells in
BatfΔZ/ΔZ mice revealed a number equivalent to WT
mice [2]. As the CD2-HA-BATF transgene directs BATF
overexpression to all T cells (thymic and peripheral) [7],
iNKT cells were re-examined and compared to numbers
in WT and BatfΔZ/ΔZ mice. The percentage of T cells
positive for interaction with glycolipid-loaded CD1d tet-
ramers was assessed by flow cytometry using single cell
suspensions from thymus, spleen and PLN. Whether cal-
culated on the basis of percentage (Figure 2A) or abso-
lute number (Figure 2B), the results confirm that iNKT
cells are under-represented in the thymus of Tg mice
and extend that observation by showing fewer iNKT
cells in the spleen and PLN as well. These data confirm




Figure 1 BATF impacts Th17 differentiation in vivo and in vitro.
A RNA prepared from stimulated, CD4+ T cells of the indicated
genotypes was analyzed for Th17-associated transcripts by qRT-PCR. B
and C Naïve CD4+ T cells of the indicated genotypes were cultured
in vitro under conditions skewing differentiation to Th1 (B) or Th17 (C)
cells. After 5 days, RNA was analyzed for the indicated transcripts by
qRT-PCR. Data were averaged from 6 (n = 6) (A) or 3 (n = 3) (B and C)
mice per genotype. Bars indicate standard error. *p values < 0.05.
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population in the thymus, yet do reveal, for the first
time, that BatfΔZ/ΔZ mice possess a statistically signifi-
cant increase in the number of peripheral iNKT cells.
In previous studies, we reported that the residual
iNKT cells in p56lckHA-BATF mice were disproportion-
ately CD44+ NK1.1- and concluded that BATF negatively
influences iNKT cell expansion and maturation [9].
However, recent studies have identified an important
sub-population of NK1.1- iNKT cells that are fully ma-
ture and function in the periphery to regulate auto-
immunity, inflammation and the host response to
infection [13]. To profile NK1.1- versus NK1.1+ iNKT
cells in Tg, WT and BatfΔZ/ΔZ mice, the flow analysis
was repeated to include an evaluation of NK1.1. As
shown in Figure 3A, Tg mice with a reduced number of
iNKT cells show a higher percentage of NK1.1- cells in
all tissues. Conversely, BatfΔZ/ΔZ mice show no bias in
the distribution of NK1.1- versus NK1.1+ iNKT cells in
thymus and spleen, but a bias toward NK1.1+ in PLN. A
graphic representation of the findings from PLN
highlight the influence of BATF levels on the distribu-
tion of NK1.1+ versus NK1.1- iNKT cells in the periphery
(Figure 3B).
Batf regulates the production of IL-17 by iNKT cells
Peripheral NK1.1- iNKT cells respond rapidly following
stimulation and produce large quantities of IL-17
[10-12]. These cells are considered a distinct lineage and
are designated as iNKT-17 cells [13]. The fact that iNKT
cells in CD2-HA-BATF mice are predominantly NK1.1-,
together with the observation that Tg animals display in-
creased IL-17 expression and CD4+Th17 cell numbers,
suggest that BATF may regulate the differentiation of
iNKT-17 cells. To examine cytokine expression by iNKT
cells, splenocytes from Tg, WT and BatfΔZ/ΔZ mice were
stimulated in vitro with glycolipid antigen (αGalCer) and
ELISA were performed (Figure 4A). As expected, IL-4 is
secreted efficiently by iNKT cells in WT and in BatfΔZ/ΔZ
cultures, but accumulates to a lower level in Tg cultures





















Figure 2 BATF alters iNKT cells numbers in vivo. A iNKT cells in single cell suspensions prepared from thymus, spleen and PLN of the
indicated genotypes were detected by flow cytometry using glycolipid-loaded mouse CD1d tetramers. Cells gated are B220- and iNKT cells are
identified as TCRβ+ Tet+ (box). Representative flow plots are shown with % iNKT cells indicated. The mean and distribution of data obtained from
at least 6 mice per genotype are presented on the right (n≥ 6). *p values < 0.05. B Analysis of iNKT cells was performed as described in A and
data expressed as total number of cells per indicated organ. The analysis of PLN was not performed. The mean and distribution of data obtained
from the organs of at least 7 mice per genotype (n≥ 7) are presented. *p values < 0.05.
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For IL-17, the level of IL-17A secreted by Tg cultures
was statistically indistinguishable from WT (Figure 4A),
indicating that NK1.1- cells overexpressing BATF readily
produce this cytokine. On the other hand, IL-17A pro-
duction by BatfΔZ/ΔZ cells, where NK1.1- and NK1.1+
iNKT cells are present in roughly equal amounts, is dra-
matically less than IL-17A production by WT cells
(Figure 4A). These data indicate that not only does
BATF influence iNKT cell numbers, it is a critical deter-
minant of IL-17 expression by iNKT cells. Flow
cytometric analysis using intracellular staining to detect
IL-17A in purified, stimulated iNKT cells from the PNL
of Tg, WT and BatfΔZ/ΔZ mice provided additional evi-
dence in support of this conclusion (Figure 4B).
DN32.D3 cells model IL-17 production by iNKT cells
IRF4/BATF protein complexes bind to DNA within the
mouse Il17a/f locus and are essential for the transactiva-
tion of the Il17a/f gene in Th17 cells [8]. However, the
mechanism by which BATF functions to regulate gene
expression in different cellular contexts, including
iNKT-17 cells where IRF4 does not play a transcriptional
role [18], continues to be investigated. Additionally,
BATF and its interaction partner proteins such as JUNB
and the IRF4 and 8 proteins [8,17], are expressed inde-
pendently of IL-17 status in other T cell lineages [1,9]
and BATF-containing protein complexes bind directly to
genes where the transcriptional outcome is the inhib-
ition of gene expression [1,4,19,20]. These facts compli-
cate proposing a unified model to explain how BATF
regulates its target genes. Therefore, to address the role
of BATF in regulating Il17a and other target genes in
iNKT cells, we sought to identify an in vitro system that
could be used for this purpose.
DN32.D3 cells are a murine CD4- CD8- iNKT cell hy-
bridoma [21] that have been used to investigate the lig-
and specificity of the iNKT TCR [22]. In response to
stimulation, DN32.D3 cells express IL-2 [23] and up-
regulate genes (Il4, Il10, Il13) encoding cytokines that
define classic, iNKT cells (Figure 5A, top panel). Stimu-
lation with αGalCer also leads to the induction of several
genes essential for iNKT cell development (Zbtb16 (Plzf ),
Nrp1, Egr1, Egr 2) [13,24] (Figure 5A, middle panel).
Interestingly, stimulation with glycolipid does not
change the level of endogenous Batf gene expression,
but instead increases expression of the genes encoding
the basic leucine zipper dimerization partners of BATF
(c-Jun, JunB and JunD) (Figure 5A, bottom panel). This
up-regulation of JUN family members explains the in-
crease in AP-1 DNA binding observed previously in
αGalCer stimulated DN32.D3 cells [9]. Stimulated
DN32.D3 cells express Rorγt mRNA (Figure 5A) and a
very high level of Il17a mRNA (Figure 5B) which are









WT Batf Z/ ZTg
B
A
Figure 3 BATF levels correlate with of NK1.1- iNKT cells. A NK1.1+ and NK1.1- iNKT cells were detected in cell suspensions from the indicated
tissues using anti-NK1.1. Shown are the mean and distribution of the percent Tet+ NK1.1+ versus Tet+ NK1.1- cells for at least 6 mice per genotype
(n≥ 6). *p values < 0.05. B Mean data from PLN in (A) were rounded to the nearest percent and presented in pie chart format to highlight the
skewing of iNKT cell populations associated with different levels of BATF expression in vivo.
Jordan-Williams et al. BMC Immunology 2013, 14:16 Page 4 of 8
http://www.biomedcentral.com/1471-2172/14/16
However, DN32.D3 cannot be classified as true iNKT-17
cells, as they are NK1.1+ [21], express Ifnγ mRNA when
stimulated and do not express Il23R (Figure 5A and C).
Nevertheless, it is worth testing the role of BATF as a
regulator of IL-17A expression in these cells.
Toward that goal, DN32.D3 cells were treated with
Batf siRNA or control siRNA, stimulated with αGalCer
loaded dimers and after 2 hr, RNA was analyzed by qRT-
PCR. Batf siRNA resulted in a 50% reduction in Batf
mRNA expression as well as a corresponding reduction
in the level of Il17a mRNA (Figure 5C). These data sup-
port a critical role for BATF in Il17a gene regulation
while demonstrating that signaling through the iNKT
cell TCR expressed by DN32.D3 cells triggers cooperat-
ing molecular events that are required for efficient IL-17
induction. We conclude that the DN32.D3 iNKT cell
line is a convenient in vitro model system in which the
details of these molecular events can be investigated
further.
Conclusions
Our studies have identified BATF as a common regula-
tor of lineage decisions in the murine immune system
that involve the expression of IL-17. BATF joins RORγt
in the transcription factor network that promotes the
differentiation of IL-17 expressing cells downstream of
pathways triggered by TGFβ and IL-6 in T cells [25] and
by a pathway dependent on TGFβ, but not IL-6, in iNKT
cells [11,26]. These studies have characterized the DN32.
D3 iNKT cell line as a model in which the regulation of
Il17a gene and protein expression by this lineage can be
investigated further. As the molecular details controlling
IL-17 production in vivo continue to emerge, new ap-
proaches to control autoimmunity, inflammation and in-
fectious disease will become a reality.
Methods
Mice
BatfΔZ/ΔZ and CD2-HA-BATF mice expressing human,
HA-tagged BATF were described previously [2,7] and
were maintained by breeding to C57Bl/6 mice (Harlan,
Indianapolis, IN). Experiments were performed using
sex-matched littermates between 6 and 12 wk of age.
Mice were housed in a specific, pathogen-free facility.
All protocols were approved by the Purdue University
Animal Care and Use Committee.
Antibodies and reagents
All antibodies, cytokines and the mouse CD1d dimers
were obtained from BD Biosciences unless otherwise
A
B
Figure 4 BATF regulates IL-17 production by primary iNKT cells. A Glycolipid-stimulated splenocytes of the indicated genotypes were
analyzed by ELISA for secreted levels of IL-4 and IL-17A after 72 h. Graphed are data averaged from 6 mice per group (n = 6). Bars indicate
standard error. *p values < 0.05. B iNKT cells were enriched from pooled PLN of the indicated genotypes, stimulated for 4 h, and NK1.1- IL-17A+
cells quantified by flow cytometry. Representative plots gated on tetramer+ cells are shown on the left with the % of cells in each quadrant
indicated. The mean and distribution of data from at least 5 mice per genotype are presented on the right (n ≥ 5). *p values < 0.05.
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specified. αGalCer was obtained from Axxora
(Farmingdale, NY). PE-labeled, CD1d tetramers, empty
or loaded with PBS-57, were obtained from the NIH
tetramer core facility.
Cell culture and the analysis of gene expression
CD4+ T cells were isolated using MACS (Miltenyi
Biotec, Auburn, CA). Cells were stimulated with anti-
CD3 and anti-CD28 Ab for 48 h as described [1]. For
in vitro differentiation assays, naïve CD4+ T cells were
isolated using MACS and cultured for 5 d under Th1
conditions [2] or under the following conditions for
Th17: 5 μg/ml anti-CD3ε, 2 μg/ml anti-CD28, 5 ng/ml
rh TGFβ, 100 ng/ml rm IL-6 and 10 μg/ml anti-IL-4 and
10 μg/ml anti-IFNγ (BioXCell, West Lebanon, NH) neu-
tralizing antibodies. Cells were re-stimulated for 6 hr
with 2 μg/ml anti-CD3ε prior to analysis. DN32.D3 cells
were cultured as described [9] and stimulated for 24 h
with plate-bound CD1d dimers +/− glycolipid prior to
analysis.
RNA was isolated using Trizol and analyzed by qRT-
PCR using SYBR green (Roche Diagnostics, Indianapolis,
IN) and an ABI 7300 real-time PCR system. Data were
normalized to Hprt expression and relative mRNA levels
calculated using ΔΔCt values. The primers for Hprt,
Actin, Batf, Il4, Il23R, Il17a and Il21 have been described
[2]. Il10 primers were from Qiagen (Gaithersburg, MD)
and additional primers (5’-3’) were
Rorγt: For TGTCCTGGGCTACCCTACTG, Rev GTG
CAGGAGTAGGCCACATT;
Ifnγ: For GGATGCATTCATGAGTATTGC, Rev CC
TTTTCCGCTTCCTGAGG;
cJun: For CAGTCCAGCAATGGGCACATCA, Rev
GGAAGCGTGTTCTGGCTATGCA;
JunB: For GACCTGCACAAGATGAACCACG, Rev
ACTGCTGAGGTTGGTGTAGACG;
JunD: For ACCTGCACAAGCAAAGCCAGCT, Rev
CGAAACTGCTCAGGTTGGCGTA;
Zbtb16: For CCCAGTTCTCAAAGGAGGATG, Rev
TTCCCACACAGCAGACAGAAG;
Nrp1: For GCCTGCTTTCTTCTCTTGGTTTCA, Rev
GCTCTGGGCACTGGGCTACA;
Erg1: For GAGGAGATGATGCTGCTGAG, Rev TG
CTGCTGCTGCTATTACC;
Erg2: For CCTCCACTCACGCCACTCTC, Rev CAC
CACCTCCACTTGCTCCTG;





Figure 5 DN32.D3 hybridoma cells display features of iNKT-17 cells. A DN32.D3 cells were stimulated with plate-bound mouse CD1d dimers
either loaded with aGalCer (+) or not (−) and after 24 h, RNA was prepared and analyzed by qRT-PCR for the indicated transcripts. Shown are the
averages of 4 samples (n = 4). Bars indicate standard error. *p values < 0.05. B DN32.D3 cultures stimulated as in (A) for 24 h and RNA analyzed for
Il17a and Ifnγ transcripts. The mean of 4 samples is presented (n = 4). Bars indicate standard error. *p < 0.05. C DN32.D3 cells were treated with
siRNA for 24 h, washed and stimulated as in (B) for 2 h. RNA was isolated and analyzed for the indicated transcripts. Data shown are averaged
from 5 samples (n = 5). Bars indicate standard error. *p values < 0.05.
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For BATF knock-down, DN32.D3 cells were cultured
for 24 h in siRNA delivery media containing 1 μM BATF
targeting (Accell siRNA smart pool) or non-targeting
siRNA (Accell non-targeting siRNA 1) (Dharmacon/
Thermo Fisher Scientific, Waltham, MA). Cells were
washed and stimulated for 2 h prior to analysis as de-
scribed above.
ELISA
Splenocytes at a density of 5×106 cells/ml were cultured
with 100 ng/ml αGalCer for 72 h. Supernatants were an-
alyzed for secreted IL-4 (BD) or IL-17A (eBiosciences,
San Diego, CA) using manufacturers’ protocols.
Flow cytometry
Axillary, brachial, inguinal, and popliteal lymph nodes
were pooled to generate PLN cultures. iNKT cells were
enriched from PLN using CD8 (Ly-2) and CD19
microbeads (Miltenyi) as described [11]. Cells were sur-
face stained after blocking with FcBlock (BD Biosciences,
Franklin Lakes, NJ) using APC-anti- TCRβ (eBioscience),
FITC-anti-B220, PE-Cy5-anti-B220, PBS-57-PE-CD1d
tetramers and PE-Cy7-anti-NK1.1. Intracellular staining
was performed as described [9] using FITC-anti-IL17A
(eBioscience) after stimulation for 4 h with 5 ng/ml
PMA and 500 ng/ml ionomycin in the presence of
Golgi-plug (BD). Data were collected on a Beckman
Coulter FC500 and analyzed using FCS Express V3 soft-
ware (DeNovo, Los Angeles, CA).
Abbreviations
AP-1: Activator Protein-1; αGalCer: α-Galactosylceramide; PLN: Peripheral
Lymph Node; qRT-PCR: quantitative Reverse Transcriptase Polymerase Chain
Reaction.
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